BiomX vs FORE Biotherapeutics

BiomX vs FORE Biotherapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BiomX is on 56/100 and FORE Biotherapeutics on 56/100.

BiomX logo
BiomXMicrobiome drug discovery company developing customized phage therapies for chronic diseases.
Try BiomX
FORE Biotherapeutics logo
FORE BiotherapeuticsPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
Try FORE Biotherapeutics

Where each one leads

BiomX

  • domain rating: 44/100 against 35/100
  • headcount: 104 against 56

FORE Biotherapeutics

  • agent readiness: 37/100 against 29/100
  • funding raised: $232M against $56.0M
  • LinkedIn following: 4,584 against 2,986

At a glance

MeasureBiomXFORE Biotherapeutics
What it isMicrobiome drug discovery company developing customized phage therapies for chronic diseases.Precision oncology company developing cancer therapies guided by proprietary functional genomics.
CategoryHealthcare, Drug Discovery, Biotech, Phage TherapyHealthcare, Drug Development, Genomics, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20172011
HeadquartersNess Ziona, IsraelPhiladelphia, United States
StatusActiveActive

Size, funding and growth

MeasureBiomXFORE Biotherapeutics
Employees10456
Headcount growthLast 12 monthsNot published+8.2%
Total funding$56.0M$232M
Latest roundSeries BSeries D-2 Extension
ValuationNot published$75.0M
LinkedIn followers2,9864,584

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBiomXFORE Biotherapeutics
StartupHub scoreOur 0-100 rating56/10056/100
Traction59/10058/100
Team70/10070/100
Search visibility23/10038/100
Quality58/10055/100
Agent readinessHow well an AI agent can read and act on the siteF (29/100)F (37/100)
Domain ratingLink authority, 0-10044/10035/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureBiomXFORE Biotherapeutics
CDNCloudflareNot detected
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Tag ManagerNot detected

BiomX vs FORE Biotherapeutics: common questions

Which is better, BiomX or FORE Biotherapeutics?

Both score the same on our 0-100 rating, so the choice comes down to the 20 data points in the tables above rather than overall company strength.

How do BiomX and FORE Biotherapeutics compare on the numbers?

BiomX leads on domain rating (44/100 against 35/100), headcount (104 against 56). FORE Biotherapeutics leads on agent readiness (37/100 against 29/100), funding raised ($232M against $56.0M), LinkedIn following (4,584 against 2,986).

Read the full BiomX review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other BiomX alternatives we track.